BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Bisoprolol

A cardioselective beta-1 adrenergic blocker. It is effective in the management of HYPERTENSION and ANGINA PECTORIS.

297+ PubMed studies analyzed · 98 RCTs · Evidence Score: 59.3

Research Domains

Bisoprolol has been studied across 15 research domains including ❤️ Cardiovascular, 🫁 Respiratory, 🫘 Kidney, 🧠 Focus & Attention, 😴 Sleep. The primary research focus is ❤️ Cardiovascular with 61% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Bisoprolol, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Carteolol
3 shared targets
Celiprolol
3 shared targets
tretoquinol
3 shared targets
cgp
2 shared targets
Xamoterol
2 shared targets
Acebutolol
3 shared targets
zenidolol
2 shared targets
talinolol
2 shared targets
Bupranolol
3 shared targets
Bunolol
3 shared targets
Loading evidence profile...

This evidence profile for Bisoprolol is generated deterministically from 297 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.